FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vytorin | Clinical Trial | drug data

Vytorin researchers call for new data-release rules

Tools

Prompted by Merck and Schering-Plough's early release of the SEAS study data on Vytorin, Duke University researchers are calling for new rules governing the release of trial data; they'd invest third parties with more power to monitor research as it's going on and guard data once it's generated. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Vytorin   Clinical Trial   drug data